ES2053989T3 - Un proceso para la preparacion de una forma de dosificacion oral, solida y de liberacion controlada. - Google Patents

Un proceso para la preparacion de una forma de dosificacion oral, solida y de liberacion controlada.

Info

Publication number
ES2053989T3
ES2053989T3 ES89305209T ES89305209T ES2053989T3 ES 2053989 T3 ES2053989 T3 ES 2053989T3 ES 89305209 T ES89305209 T ES 89305209T ES 89305209 T ES89305209 T ES 89305209T ES 2053989 T3 ES2053989 T3 ES 2053989T3
Authority
ES
Spain
Prior art keywords
dosage form
solid
controlled release
oral dosage
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89305209T
Other languages
English (en)
Inventor
Joanne Heafield
Stewart Thomas Leslie
Sandra Therese Antoi Malkowska
Philip John Neale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Application granted granted Critical
Publication of ES2053989T3 publication Critical patent/ES2053989T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA INVENCION SE REFIERE A UNA DOSIFICACION ORAL SOLIDA, DE LIBERACION CONTROLADA, QUE CONTIENE UNA 3 - ALQUIL - XANTINA, PREFERIBLEMENTE TEOFILINA, POR LO MENOS UN POLIMERO HIDROFILICO O HIDROFOBICO, AL MENOS UNA CERA CON UN PUNTO DE FUSION ENTRE 25 Y 90 (GRADOS) C Y ENTRE UN 3 Y UN 10% (EN PESO) DE AGUA. PREFERIBLEMENTE LA FORMA DE DOSIFICACION ES UN COMPRIMIDO CON UN CONTENIDO DE AGUA ENTRE 4 Y 9% LA CANTIDAD DE AGUA PRESENTE EN LA FORMA DE DOSIFICACION, DETERMINA LA VELOCIDAD DE LIBERACION DE LA 3 ALQUILXANTINA.
ES89305209T 1988-06-02 1989-05-23 Un proceso para la preparacion de una forma de dosificacion oral, solida y de liberacion controlada. Expired - Lifetime ES2053989T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813064A GB8813064D0 (en) 1988-06-02 1988-06-02 Controlled release dosage forms having defined water content

Publications (1)

Publication Number Publication Date
ES2053989T3 true ES2053989T3 (es) 1994-08-01

Family

ID=10637952

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89305209T Expired - Lifetime ES2053989T3 (es) 1988-06-02 1989-05-23 Un proceso para la preparacion de una forma de dosificacion oral, solida y de liberacion controlada.

Country Status (19)

Country Link
US (1) US5091189A (es)
EP (1) EP0344960B1 (es)
JP (1) JPH0816060B2 (es)
KR (1) KR0136279B1 (es)
AT (1) ATE83925T1 (es)
AU (1) AU610401B2 (es)
CA (1) CA1323834C (es)
DE (1) DE68904119T2 (es)
DK (1) DK175130B1 (es)
ES (1) ES2053989T3 (es)
FI (1) FI93695C (es)
GB (2) GB8813064D0 (es)
GR (1) GR3007088T3 (es)
IE (1) IE61998B1 (es)
IL (1) IL90462A (es)
NO (1) NO176232C (es)
NZ (1) NZ229372A (es)
PT (1) PT90722B (es)
ZA (1) ZA894201B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
DK1685839T3 (da) 1997-12-22 2013-06-24 Euro Celtique Sa Farmaceutisk oral doseringsform omfattende en kombination af en opioidagonist og opioidantagonist
CN1204890C (zh) * 1997-12-22 2005-06-08 欧罗赛铁克股份有限公司 防止阿片样物质滥用的方法
AU1738800A (en) 1998-11-23 2000-06-13 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
AU776666B2 (en) 2000-02-08 2004-09-16 Euro-Celtique S.A. Tamper-resistant oral opioid agonist formulations
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US7943173B2 (en) * 2001-07-18 2011-05-17 Purdue Pharma L.P. Pharmaceutical combinations of oxycodone and naloxone
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US20030157168A1 (en) * 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
WO2003013525A1 (en) 2001-08-06 2003-02-20 Euro-Celtique S.A. Opioid agonist formulations with releasable and sequestered antagonist
IN192180B (es) * 2001-09-28 2004-03-06 Ranbaxy Lab
CA2479350A1 (en) * 2002-03-15 2003-09-25 Cypress Bioscience, Inc. Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
CA2478515C (en) 2002-04-05 2010-09-28 Purdue Pharma Pharmaceutical preparation containing oxycodone and naloxone
DK1551372T3 (en) 2002-09-20 2018-07-23 Alpharma Pharmaceuticals Llc SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
JP2006515008A (ja) * 2003-01-28 2006-05-18 コレギウム ファーマシューティカル， インコーポレイテッド 経口投与のためのミルナシプランの多粒子状組成物
US20040202717A1 (en) * 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) * 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EA012220B1 (ru) * 2004-10-19 2009-08-28 Крка, Товарна Здравил, Д. Д., Ново Место Твёрдая фармацевтическая композиция, содержащая донепезила гидрохлорид
EP1702558A1 (en) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
ZA200802602B (en) * 2005-08-24 2009-10-28 Rubicon Res Pvt Ltd Controlled release formulation
KR101486228B1 (ko) * 2006-06-19 2015-01-26 알파마 파머슈티컬스 엘엘씨 약제학적 조성물
CA2662358C (en) * 2006-09-29 2015-02-10 The Procter & Gamble Company Oral compositions containing gel networks
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
AU2008346870A1 (en) * 2007-12-17 2009-07-16 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
KR20130105935A (ko) * 2008-07-07 2013-09-26 유로-셀티큐 에스.에이. 요폐의 치료를 위한 아편유사제 길항제의 용도
WO2010103039A1 (en) 2009-03-10 2010-09-16 Euro-Celtique S.A. Immediate release pharmaceutical compositions comprising oxycodone and naloxone
KR20180037074A (ko) 2013-07-23 2018-04-10 유로-셀티큐 에스.에이. 장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물
CN114053235B (zh) * 2020-08-07 2023-07-18 广州白云山光华制药股份有限公司 茶碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
FR2535202B1 (fr) * 1982-11-03 1985-08-09 Fabre Sa Pierre Comprimes de theophylline a liberation controlee et leur procede de fabrication
US4743247A (en) * 1984-08-13 1988-05-10 Alza Corporation Process for manufacturing dosage form
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
ES2058111T3 (es) * 1986-06-10 1994-11-01 Euro Celtique Sa Composicion de liberacion controlada de dihidrocodeina.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids

Also Published As

Publication number Publication date
JPH0816060B2 (ja) 1996-02-21
IL90462A0 (en) 1990-01-18
NO176232C (no) 1995-03-01
EP0344960A3 (en) 1990-03-07
GB8813064D0 (en) 1988-07-06
GB2219207A (en) 1989-12-06
KR0136279B1 (ko) 1998-04-25
CA1323834C (en) 1993-11-02
NO892229D0 (no) 1989-06-01
DK266889A (da) 1989-12-03
DE68904119D1 (de) 1993-02-11
IL90462A (en) 1993-01-31
GR3007088T3 (es) 1993-07-30
PT90722A (pt) 1989-12-29
IE61998B1 (en) 1994-12-14
FI93695B (fi) 1995-02-15
IE891744L (en) 1989-12-02
DE68904119T2 (de) 1993-06-09
EP0344960B1 (en) 1992-12-30
NO892229L (no) 1989-12-04
PT90722B (pt) 1994-11-30
DK175130B1 (da) 2004-06-14
GB2219207B (en) 1992-01-02
DK266889D0 (da) 1989-06-01
JPH0225420A (ja) 1990-01-26
FI93695C (fi) 1995-05-26
FI892664L (fi) 1989-12-03
ZA894201B (en) 1990-03-28
AU610401B2 (en) 1991-05-16
KR900000077A (ko) 1990-01-30
US5091189A (en) 1992-02-25
GB8911629D0 (en) 1989-07-05
ATE83925T1 (de) 1993-01-15
FI892664A0 (fi) 1989-06-01
AU3512789A (en) 1989-12-07
NZ229372A (en) 1991-07-26
NO176232B (no) 1994-11-21
EP0344960A2 (en) 1989-12-06

Similar Documents

Publication Publication Date Title
DE68904119D1 (de) Dosisformen mit definiertem wassergehalt zur gesteuerten freigabe.
LV5503A3 (lv) Panemiens omeprazola salu iegusanai
ES2053567T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica de liberacion controlada.
BE1002159A5 (fr) Adsorbats medicamenteux.
ES2027005T3 (es) Procedimiento para preparar una formulacion farmaceutica de liberacion controlada de acrivastina.
ITBS920092A0 (it) Composizione per la liberazione prolungata e controllata di una sostanza medicamentosa peptica e procedimento per la sua preparazione
KR0141473B1 (en) Dispensing device
BE901359A (fr) Composition pharmaceutique a absorption reglee.
ES2036457B1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
ES8403316A1 (es) Un procedimiento para la preparacion de una composicion a base de sales de cinc y sales de fluoruro.
ES2044156T3 (es) Jabon transparente que contiene un 1,2-alcanodiol.
ES509179A0 (es) "un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en forma de pastillas que contiene como agente terapeutico ibuprofen o flurbiprofen".
IT1178511B (it) Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
IT1227010B (it) Composizione orale solida per la cura o profilassi di mancanza di potassio e magnesio e metodo per applicarla
ATE66784T1 (de) Nahrungsgemisch fuer alte menschen.
JPS57118511A (en) Gradually releasing preparation
ATE32980T1 (de) Tabletten mit ph-unabhaengiger kontrollierter freisetzung.
FR2636239B1 (fr) Composition desinfectante pour la prevention de la mammite subclinique chez les ruminants
DE3850659D1 (de) Zahnfüllungsmaterial.
NO157963C (no) Tannpleiemidler som inneholder funksjonelle, agglomererte, spettede partikler.
CU21980A1 (es) Composicion mineralizante dental y su forma farmaceutica
YU70804A (sh) Oksikodonski derivati koji se kontrolisano ispuštaju
GT198500045A (es) Una composicion para la higiene oral
MX172016B (es) Composicion de cemento dental de fosfato de zinc y proceso para su preparacion
ATE98484T1 (de) Analgetische antacide brausezusammensetzung mit reduziertem natriumgehalt.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 344960

Country of ref document: ES